{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:22:48Z","timestamp":1792264968362,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T00:00:00Z","timestamp":1595116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T00:00:00Z","timestamp":1595116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL134644"],"award-info":[{"award-number":["T32 HL134644"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25GM133328"],"award-info":[{"award-number":["R25GM133328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The outbreak and continued spread of the novel coronavirus disease 2019 (COVID-19) is a preeminent global health threat that has resulted in the infection of over 11.5 million people worldwide. In addition, the pandemic has claimed the lives of over 530,000 people worldwide. Age and the presence of underlying comorbid conditions have been found to be key determinants of patient mortality. One such comorbidity is the presence of an oncological malignancy, with cancer patients exhibiting an approximate two-fold increase in mortality rate. Due to a lack of data, no consensus has been reached about the best practices for the diagnosis and treatment of cancer patients. Interestingly, two independent research groups have discovered that Withaferin A (WFA), a steroidal lactone with anti-inflammatory and anti-tumorigenic properties, may bind to the viral spike (S-) protein of SARS-CoV-2. Further, preliminary data from our research group has demonstrated that WFA does not alter expression of ACE2 in the lungs of tumor-bearing female mice. Downregulation of ACE2 has recently been demonstrated to increase the severity of COVID-19. Therefore, WFA demonstrates real potential as a therapeutic agent to treat or prevent the spread of COVID-19 due to the reported interference in viral S-protein to host receptor binding and its lack of effect on ACE2 expression in the lungs.<\/jats:p>","DOI":"10.1186\/s13048-020-00684-x","type":"journal-article","created":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T16:03:28Z","timestamp":1595174608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Withaferin A: a potential therapeutic agent against COVID-19 infection"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6516-8096","authenticated-orcid":false,"given":"Alex R.","family":"Straughn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1410-2625","authenticated-orcid":false,"given":"Sham S.","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,19]]},"reference":[{"key":"684_CR1","first-page":"2","volume":"27","author":"II Bogoch","year":"2020","unstructured":"Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med. 2020;27:2.","journal-title":"J Travel Med"},{"key":"684_CR2","doi-asserted-by":"crossref","unstructured":"Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, Brichler S, Cohen Y. SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents. 2020;106006.","DOI":"10.1016\/j.ijantimicag.2020.106006"},{"key":"684_CR3","unstructured":"COVID-19 Coronavirus Pandemic [https:\/\/www.worldometers.info\/coronavirus\/]."},{"issue":"3","key":"684_CR4","volume":"12","author":"SA Hassan","year":"2020","unstructured":"Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus. 2020;12(3):e7355.","journal-title":"Cureus"},{"issue":"6965","key":"684_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450\u20134.","journal-title":"Nature"},{"issue":"1","key":"684_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.2162","volume":"212","author":"I Hamming","year":"2007","unstructured":"Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, Timens W, Turner AJ, Navis G, van Goor H. The emerging role of ACE2 in physiology and disease. J Pathol. 2007;212(1):1\u201311.","journal-title":"J Pathol"},{"issue":"1","key":"684_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","volume":"128","author":"K Kuba","year":"2010","unstructured":"Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010;128(1):119\u201328.","journal-title":"Pharmacol Ther"},{"issue":"7477","key":"684_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nature12711","volume":"503","author":"XY Ge","year":"2013","unstructured":"Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, Mazet JK, Hu B, Zhang W, Peng C, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503(7477):535\u20138.","journal-title":"Nature"},{"issue":"10","key":"684_CR9","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, Raizada MK, Grant MB, Oudit GY. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126(10):1456\u201374.","journal-title":"Circ Res"},{"issue":"3","key":"684_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7(3):226\u201336.","journal-title":"Nat Rev Microbiol"},{"issue":"6483","key":"684_CR11","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260\u20133.","journal-title":"Science"},{"issue":"5","key":"684_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11912-020-00934-7","volume":"22","author":"R Gosain","year":"2020","unstructured":"Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. COVID-19 and Cancer: a comprehensive review. Curr Oncol Rep. 2020;22(5):53.","journal-title":"Curr Oncol Rep"},{"key":"684_CR13","unstructured":"Clinical management of severse acute respiratory infection (SARI) when COVID-19 desease is suspected. https:\/\/resourcecentre.savethechildren.net\/node\/17278\/pdf\/who_clinical-management-of-novel-cov_march_2020.pdf."},{"key":"684_CR14","doi-asserted-by":"crossref","unstructured":"The epidemiological characteristics of an outbreak of 2019 Novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145\u201351.","DOI":"10.46234\/ccdcw2020.032"},{"key":"684_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3389\/fonc.2020.00648","volume":"10","author":"L Fratino","year":"2020","unstructured":"Fratino L, Procopio G, Di Maio M, Cinieri S, Leo S, Beretta G. Coronavirus: older persons with Cancer in Italy in the COVID-19 pandemic. Front Oncol. 2020;10:648.","journal-title":"Front Oncol"},{"key":"684_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3389\/fonc.2020.00734","volume":"10","author":"O Brunetti","year":"2020","unstructured":"Brunetti O, Derakhshani A, Baradaran B, Galvano A, Russo A, Silvestris N. COVID-19 infection in Cancer patients: how can oncologists Deal with these patients? Front Oncol. 2020;10:734.","journal-title":"Front Oncol"},{"key":"684_CR17","doi-asserted-by":"crossref","unstructured":"Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q, et al. Patients with Cancer appear more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020.","DOI":"10.1158\/2159-8290.CD-20-0422"},{"issue":"3","key":"684_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335\u20137.","journal-title":"Lancet Oncol"},{"key":"684_CR19","doi-asserted-by":"crossref","unstructured":"Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, Pradhan K, Thota R, Reissman S, Sparano JA, et al. Case fatality rate of Cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020.","DOI":"10.1158\/2159-8290.CD-20-0516"},{"key":"684_CR20","doi-asserted-by":"crossref","unstructured":"Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, Jia P, Guan HQ, Peng L, Chen Y, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020.","DOI":"10.1016\/j.annonc.2020.03.296"},{"issue":"4","key":"684_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41591-020-0822-7","volume":"26","author":"JT Wu","year":"2020","unstructured":"Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, Cowling BJ, Lipsitch M, Leung GM. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020;26(4):506\u201310.","journal-title":"Nat Med"},{"key":"684_CR22","unstructured":"Disruptions in Cancer Care in the Era of COVID-19 [https:\/\/www.medscape.com\/viewarticle\/927215]."},{"issue":"20","key":"684_CR23","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.2217\/fon-2020-0369","volume":"16","author":"EM Stroppa","year":"2020","unstructured":"Stroppa EM, Toscani I, Citterio C, Anselmi E, Zaffignani E, Codeluppi M, Cavanna L. Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy). Future Oncol. 2020;16(20):1425\u201332.","journal-title":"Future Oncol"},{"issue":"1","key":"684_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ygyno.2020.04.709","volume":"158","author":"Y Chen","year":"2020","unstructured":"Chen Y, Li G. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak. Gynecol Oncol. 2020;158(1):44\u20136.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"684_CR25","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e65","volume":"31","author":"Y Kobayashi","year":"2020","unstructured":"Kobayashi Y, Suh DH, Aoki D, Kim JW. Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea. J Gynecol Oncol. 2020;31(3):e65.","journal-title":"J Gynecol Oncol"},{"key":"684_CR26","doi-asserted-by":"crossref","unstructured":"Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, Wolff RA, Ibrahim NK, Chua MLK, Hotte SJ, et al. A practical approach to the Management of Cancer Patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist. 2020.","DOI":"10.1634\/theoncologist.2020-0213"},{"key":"684_CR27","first-page":"21","volume":"20","author":"R Dutta","year":"2019","unstructured":"Dutta R, Khalil R, Green R, Mohapatra SS, Mohapatra S. Withania somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology. Int J Mol Sci. 2019;20:21.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"684_CR28","first-page":"932","volume":"23","author":"A Fugner","year":"1973","unstructured":"Fugner A. Inhibition of immunologically induced inflammation by plant steroid WITHAFERIN-a. Arzneimittel-Forschung\/Drug Research. 1973;23(7):932\u20135.","journal-title":"Arzneimittel-Forschung\/Drug Research"},{"issue":"43","key":"684_CR29","doi-asserted-by":"publisher","first-page":"74494","DOI":"10.18632\/oncotarget.20170","volume":"8","author":"SS Kakar","year":"2017","unstructured":"Kakar SS, Parte S, Carter K, Joshua IG, Worth C, Rameshwar P, Ratajczak MZ. Withaferin a (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells. Oncotarget. 2017;8(43):74494\u2013505.","journal-title":"Oncotarget"},{"issue":"1","key":"684_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13048-019-0586-1","volume":"12","author":"AR Straughn","year":"2019","unstructured":"Straughn AR, Kakar SS. Withaferin a ameliorates ovarian cancer-induced cachexia and proinflammatory signaling. J Ovarian Res. 2019;12(1):115.","journal-title":"J Ovarian Res"},{"issue":"6","key":"684_CR31","first-page":"607","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `cytokine Storm' in COVID-19. J Inf Secur. 2020;80(6):607\u201313.","journal-title":"J Inf Secur"},{"key":"684_CR32","volume-title":"Withanone from Withania somnifera may inhibit novel coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor","author":"A Balkrishna","year":"2020","unstructured":"Balkrishna A, Pokhrel S, Singh J, Varshney A: Withanone from Withania somnifera may inhibit novel coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor. In. Research Square; 2020."},{"key":"684_CR33","volume-title":"Evaluation of traditional ayurvedic preparation for prevention and management of the novel coronavirus (SARS-CoV-2) using molecular docking approach","author":"DK Maurya","year":"2020","unstructured":"Maurya DK, Sharma D: Evaluation of traditional ayurvedic preparation for prevention and management of the novel coronavirus (SARS-CoV-2) using molecular docking approach. In. ChemRxiv; 2020."},{"key":"684_CR34","doi-asserted-by":"crossref","unstructured":"Kumar V, Dhanjal JK, Kaul SC, Wadhwa R, Sundar D. Withanone and Caffeic acid Phenethyl Ester are predicted to interact with Main protease (M (pro)) of SARS-CoV-2 and inhibit its activity. J Biomol Struct Dyn. 2020:1\u201317.","DOI":"10.1080\/07391102.2020.1772108"},{"issue":"10","key":"684_CR35","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.biocel.2013.05.035","volume":"45","author":"T Yoshida","year":"2013","unstructured":"Yoshida T, Tabony AM, Galvez S, Mitch WE, Higashi Y, Sukhanov S, Delafontaine P. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia. Int J Biochem Cell Biol. 2013;45(10):2322\u201332.","journal-title":"Int J Biochem Cell Biol"},{"key":"684_CR36","doi-asserted-by":"crossref","unstructured":"Wang K, Gheblawi M, Oudit GY. Angiotensin converting enzyme 2: a double-edged sword. Circulation. 2020.","DOI":"10.1161\/CIRCULATIONAHA.120.047049"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00684-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-020-00684-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00684-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T23:06:00Z","timestamp":1626649560000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-020-00684-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,19]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1186\/s13048-020-00684-x","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,19]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}